For research use only. Not for therapeutic Use.
The first GTP-competitive inhibitor of human cytosolic phosphoenolpyruvate carboxykinase (PEPCK or cPEPCK) with low submicromolar IC50 values.
KEYWORDS: cPEPCK inhibitor | supplier | cPEPCK inhibitor | CAS [628279-07-2] | Gluconeogenesis | PEPCK | GTP-competitive | human | cytosolic | phosphoenolpyruvate carboxykinase | glucose homeostasis | Type 2 | diabetes
| Catalog Number | R046009 |
| CAS Number | 628279-07-2 |
| Molecular Formula | C25H26FN5O3 |
| Purity | ≥95% |
| IUPAC Name | N-[4-[[3-butyl-1-[(2-fluorophenyl)methyl]-2,6-dioxo-7H-purin-8-yl]methyl]phenyl]acetamide |
| InChI | InChI=1S/C25H26FN5O3/c1-3-4-13-30-23-22(24(33)31(25(30)34)15-18-7-5-6-8-20(18)26)28-21(29-23)14-17-9-11-19(12-10-17)27-16(2)32/h5-12H,3-4,13-15H2,1-2H3,(H,27,32)(H,28,29) |
| SMILES | CCCCN1C2=C(C(=O)N(C1=O)CC3=CC=CC=C3F)NC(=N2)CC4=CC=C(C=C4)NC(=O)C |
| Reference | LH Foley et al. Modified 3-alkyl-1,8-dibenzylxanthines as GTP-competitive inhibitors of phosphoenolpyruvate carboxykinase. Bioorg. Med. Chem. Lett. 2003, 13(20), 3607-10.
LH Foley et al. X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines. Bioorg. Med. Chem. Lett. 2003, 13(21), 3871-4.
SL Pietranico et al. C-8 Modifications of 3-alkyl-1,8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase. Bioorg. Med. Chem. Lett. 2007, 17(14), 3835-9. |
